DSM B.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
01 nov 2005 - 08:16
Statutaire naam
DSM B.V.
Titel
DSM to expand manufacturing base for anti-infectives in India
Bericht
DSM will invest in the expansion of DSM Anti-Infectives’ production facilities at Toansa (India). The investment will increase production of the penicillin-related intermediate 6-APA and of active pharmaceutical ingredients (APIs). The expansion is part of the global restructuring program at the DSM Anti-Infectives business group that DSM announced in December 2004 with the aim of improving profitability in the short term and retaining DSM’s leading positions in the global market for penicillin and penicillin derivatives.
Gerelateerde downloads
Datum laatste update: 13 maart 2026